145 related articles for article (PubMed ID: 11989967)
1. Expression of B-cell translocation gene 2 protein in normal human tissues.
Melamed J; Kernizan S; Walden PD
Tissue Cell; 2002 Feb; 34(1):28-32. PubMed ID: 11989967
[TBL] [Abstract][Full Text] [Related]
2. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?
Tirone F
J Cell Physiol; 2001 May; 187(2):155-65. PubMed ID: 11267995
[TBL] [Abstract][Full Text] [Related]
3. BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells.
el-Ghissassi F; Valsesia-Wittmann S; Falette N; Duriez C; Walden PD; Puisieux A
Oncogene; 2002 Oct; 21(44):6772-78. PubMed ID: 12360398
[TBL] [Abstract][Full Text] [Related]
4. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway.
Rouault JP; Falette N; Guéhenneux F; Guillot C; Rimokh R; Wang Q; Berthet C; Moyret-Lalle C; Savatier P; Pain B; Shaw P; Berger R; Samarut J; Magaud JP; Ozturk M; Samarut C; Puisieux A
Nat Genet; 1996 Dec; 14(4):482-6. PubMed ID: 8944033
[TBL] [Abstract][Full Text] [Related]
5. TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.
Lim IK
J Cancer Res Clin Oncol; 2006 Jul; 132(7):417-26. PubMed ID: 16456675
[TBL] [Abstract][Full Text] [Related]
6. BTG gene expression in the p53-dependent and -independent cellular response to DNA damage.
Cortes U; Moyret-Lalle C; Falette N; Duriez C; Ghissassi FE; Barnas C; Morel AP; Hainaut P; Magaud JP; Puisieux A
Mol Carcinog; 2000 Feb; 27(2):57-64. PubMed ID: 10657898
[TBL] [Abstract][Full Text] [Related]
7. Rapid induction of PC3/BTG2 gene by hepatopoietin or partial hepatectomy and its mRNA expression in hepatocellular carcinoma.
Zhang ZM; Wang G; Chen C; Yang ZX; Jin F; San JL; Xu W; Li Q; Li ZP; Wang D
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):288-93. PubMed ID: 19502170
[TBL] [Abstract][Full Text] [Related]
8. B cell translocation gene 2 enhances susceptibility of HeLa cells to doxorubicin-induced oxidative damage.
Lim YB; Park TJ; Lim IK
J Biol Chem; 2008 Nov; 283(48):33110-8. PubMed ID: 18840609
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Btg2(/TIS21/PC3) expression via reactive oxygen species-protein kinase C-ΝFκΒ pathway under stress conditions.
Imran M; Lim IK
Cell Signal; 2013 Dec; 25(12):2400-12. PubMed ID: 23876794
[TBL] [Abstract][Full Text] [Related]
10. Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein.
Kawakubo H; Brachtel E; Hayashida T; Yeo G; Kish J; Muzikansky A; Walden PD; Maheswaran S
Cancer Res; 2006 Jul; 66(14):7075-82. PubMed ID: 16849553
[TBL] [Abstract][Full Text] [Related]
11. The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene.
Duriez C; Falette N; Audoynaud C; Moyret-Lalle C; Bensaad K; Courtois S; Wang Q; Soussi T; Puisieux A
Gene; 2002 Jan; 282(1-2):207-14. PubMed ID: 11814693
[TBL] [Abstract][Full Text] [Related]
12. TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans-retinoic acid.
Imran M; Park TJ; Lim IK
Eur J Cancer; 2012 Oct; 48(15):2474-85. PubMed ID: 22341854
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, degradation, and subcellular localization of proteins encoded by the primary response genes TIS7/PC4 and TIS21/PC3.
Varnum BC; Reddy ST; Koski RA; Herschman HR
J Cell Physiol; 1994 Jan; 158(1):205-13. PubMed ID: 8263025
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific expression of B-cell translocation gene 2 (BTG2) and its function in T-cell immune responses in a transgenic mouse model.
Terra R; Luo H; Qiao X; Wu J
Int Immunol; 2008 Mar; 20(3):317-26. PubMed ID: 18195048
[TBL] [Abstract][Full Text] [Related]
15. Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer.
Kawakubo H; Carey JL; Brachtel E; Gupta V; Green JE; Walden PD; Maheswaran S
Oncogene; 2004 Oct; 23(50):8310-9. PubMed ID: 15378000
[TBL] [Abstract][Full Text] [Related]
16. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling.
Donato LJ; Suh JH; Noy N
Cancer Res; 2007 Jan; 67(2):609-15. PubMed ID: 17234770
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.
Choi JA; Jung YS; Kim JY; Kim HM; Lim IK
Oncogene; 2016 Jan; 35(1):83-93. PubMed ID: 25798836
[TBL] [Abstract][Full Text] [Related]
18. TIS21/BTG2/PC3 and cyclin D1 are key determinants of nuclear diacylglycerol kinase-zeta-dependent cell cycle arrest.
Evangelisti C; Astolfi A; Gaboardi GC; Tazzari P; Pession A; Goto K; Martelli AM
Cell Signal; 2009 May; 21(5):801-9. PubMed ID: 19263516
[TBL] [Abstract][Full Text] [Related]
19. Expression of the antiproliferative gene TIS21 at the onset of neurogenesis identifies single neuroepithelial cells that switch from proliferative to neuron-generating division.
Iacopetti P; Michelini M; Stuckmann I; Oback B; Aaku-Saraste E; Huttner WB
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4639-44. PubMed ID: 10200315
[TBL] [Abstract][Full Text] [Related]
20. Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2.
Tsui KH; Hsieh WC; Lin MH; Chang PL; Juang HH
Prostate; 2008 May; 68(6):610-9. PubMed ID: 18196550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
